Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Quetiapine and Lithium Monotherapy in Bipolar Depression (EMBOLDEN I)
NCT00206141Phase 3Completed
- Sponsor
- AstraZeneca
- Start
- Aug 2005
- Modality
- Small Molecules
- Countries
- 16
01
Overview
A Phase 3 trial of quetiapine in bipolar disorder (BD), sponsored by AstraZeneca. Started Aug 2005; status: completed.
02
Drugs
quetiapine
03
Conditions
bipolar disorder (BD)
Beyond the preview
Go deeper on NCT00206141.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00206141.